These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8382875)

  • 21. Ganciclovir prophylaxis to prevent CMV disease in kidney recipients undergoing anti-lymphocyte globulin treatment for acute rejection.
    Dickenmann MJ; Kabulbayev K; Steiger J; Cathomas G; Reusser P; Tamm M
    Clin Microbiol Infect; 2004 Apr; 10(4):337-9. PubMed ID: 15059125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
    Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J
    Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
    Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
    Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir.
    Palmer SM; Grinnan DC; Diane Reams B; Steele MP; Messier RH; Duane Davis R
    Clin Transplant; 2004 Apr; 18(2):179-85. PubMed ID: 15016133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus infections in the immunocompromised transplant patient. Prevention of cytomegalovirus disease with intravenous immune globulin.
    Snydman DR
    Transplant Proc; 1991 Apr; 23(2 Suppl 1):20-5. PubMed ID: 1647560
    [No Abstract]   [Full Text] [Related]  

  • 27. CMV infection and disease in kidney and pancreas transplant recipients.
    Keay S
    Transpl Infect Dis; 1999; 1 Suppl 1():19-24. PubMed ID: 11565582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
    Guttmann RD; Flemming C
    Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of cytomegalovirus prophylaxis in renal retransplantation.
    Singh TP; Gruber SA; Lempert N; Freed B; Conti DJ
    Transplant Proc; 1995 Feb; 27(1):964-5. PubMed ID: 7879247
    [No Abstract]   [Full Text] [Related]  

  • 30. No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group.
    Ruutu T; Ljungman P; Brinch L; Lenhoff S; Lönnqvist B; Ringdén O; Ruutu P; Volin L; Albrechtsen D; Sallerfors B; Ebeling F; Myllylä G
    Bone Marrow Transplant; 1997 Feb; 19(3):233-6. PubMed ID: 9028551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytomegalovirus prophylaxis with intravenous polyvalent immunoglobulin in high-risk renal transplant recipients.
    Leroy F; Sechet A; Abou Ayache R; Thierry A; Belmouaz S; Desport E; Bauwens M; Bridoux F; Touchard G
    Transplant Proc; 2006 Sep; 38(7):2324-6. PubMed ID: 16980080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ganciclovir in cytomegalovirus prophylaxis in high-risk pediatric renal transplant recipients.
    Prokurat S; Drabik E; Grenda R; Vogt E
    Transplant Proc; 1993 Aug; 25(4):2577. PubMed ID: 8395104
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection.
    Kranz B; Vester U; Wingen AM; Nadalin S; Paul A; Broelsch CE; Hoyer PF
    Pediatr Transplant; 2008 Jun; 12(4):474-8. PubMed ID: 18466436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation.
    Ruttmann E; Geltner C; Bucher B; Ulmer H; Höfer D; Hangler HB; Semsroth S; Margreiter R; Laufer G; Müller LC
    Transplantation; 2006 May; 81(10):1415-20. PubMed ID: 16732179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis of CMVIG studies for the prevention and treatment of CMV infection in transplant patients.
    Wittes JT; Kelly A; Plante KM
    Transplant Proc; 1996 Dec; 28(6 Suppl 2):17-24. PubMed ID: 9037273
    [No Abstract]   [Full Text] [Related]  

  • 36. The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.
    Reischig T; Jindra P; Svecová M; Kormunda S; Opatrný K; Treska V
    J Clin Virol; 2006 Jun; 36(2):146-51. PubMed ID: 16531113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytomegalovirus disease in renal transplant recipients: a single-center experience.
    Basri N; Abdullah KA; Shaheen FA
    Exp Clin Transplant; 2007 Jun; 5(1):601-3. PubMed ID: 17617050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized double-blind study of the effect of prophylactic immune globulin on the incidence and severity of CMV infection in the liver transplant recipient.
    Cofer JB; Morris CA; Sutker WL; Husberg BS; Goldstein RM; Gonwa TA; Klintmalm GB
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1525-7. PubMed ID: 1846477
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevention of cytomegalovirus disease in transplant recipients.
    Pidgeon GB; Bailey RR
    N Z Med J; 1993 Nov; 106(967):468-9. PubMed ID: 8233192
    [No Abstract]   [Full Text] [Related]  

  • 40. The usefulness of hyperimmune globulin for treatment of overt cytomegalovirus infection in allograft recipients.
    Rancewicz Z; Halama G; Smogorzewski M; Durlik M; Rowinska D; Lao M; Juskowa J; Wyzgal J
    Transplant Proc; 1990 Aug; 22(4):1818-9. PubMed ID: 2167538
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.